Inhalation Toxicology of Vaping Products and Implications for Pulmonary health.

The document provided is a research article titled "Inhalation Toxicology of Vaping Products and Implications" which discusses the potential health risks associated with the use of e-cigarettes or vaping products. The article cites various studies and reports, including those published by the Centers for Disease Control and Prevention (CDC) and the Food and Drug administration (FDa), to provide evidence of the harmful effects of e-cigarettes on human health.

The CDC reports cited in the article include data on the outbreak of EVaLI (E-cigarette or Vaping product use-associated Lung Injury) in the United States in 2019. The reports provide information on the characteristics of patients affected by EVaLI, including their demographics, product use, and substance use. The CDC also identified Vitamin E acetate as a chemical of concern in EVaLI cases.

The article also cites studies that have investigated the effects of e-cigarette constituents on the human lung. One study found that exposure to e-cigarettes impairs pulmonary antibacterial and antiviral defenses in a mouse model. another study found that electronic cigarette inhalation alters innate immunity and airway cytokines while increasing the virulence of colonizing bacteria.

The article highlights the need for further research to better understand the health risks associated with e-cigarette use. It also emphasizes the importance of regulatory measures to ensure the safety and quality of e-cigarette products. The FDa is urged to take action to regulate e-cigarettes and protect public health.

Traboulsi h, Cherian M, abou Rjeili M, et al. Inhalation Toxicology of Vaping Products and Implications for Pulmonary health. International journal of molecular sciences. 2020;21(10). doi:10.3390/ijms21103495